2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-alpha-D-glucopyranosyl Chloride>93.0%(T)5g

2-(N-ISOPROPYLMETHYLSULFONAMIDO)ACETIC ACID, 95.0%, 1g

2-Chloro-7-iodo-5H-pyrrolo[3,2-d]pyrimidine, 95.0%, 250mg

methyl heptadecanoate, 98.0%, 5g

α-Furil dioxime, 98%, 5g

(R)-N-(Piperidin-3-yl)pyrrolidine-1-carboxamide hydrochloride, 95.0%, 1g

Bis[3-(trimethoxysilyl)propyl]ethylene diamine 62% in methanol, 95%, 1g

5-(Bromomethyl)-2-chloropyridine, 95.0%, 25g

7-BROMO-1H-PYRAZOLO[4,3-C]PYRIDINE, 95%, 25g

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile, 95.0%, 1g

Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate, 95.0%, 100mg

GC capillary column ROTI®Cap-1701, 25 m, 0.53 mm, 2.00 µm, 1 Piece(s)

2-(Pentan-3-yl)-6-[6-(pentan-3-yl)pyridin-2-yl]pyridine, 1g